| 8:00-12:50 |
Colorectal -ROOM J-
Chair: J Lange (Switzerland)/JV Roig (Spain) |
| 8:00-8:12 |
Surgical indications in Familial Adenomatous Polyposis
M. Moshkowitz (Israel)
|
| 8:12-8:24 |
Chemoprevention of Colorectal Cancer
Á Ferrández (Spain) |
| 8:24-8:36 |
When should genetic testing be ordered?
A Castells (Spain) |
| 8:36-8:48 |
Capsules and new generation scopes for colorectal cancer screening
M. Moshkowitz (Israel)
|
| 8:48-9:00 |
Standards in MRI in rectal cancer
G Brown (UK) |
| 9:00-9:12 |
Which imaging studies do we need in the staging of colorectal Cancer?
JR Ayuso (Spain) |
| 9:12-9:24 |
Long term outcome of laparoscopic colorectal cancer resections E Haglind (Sweden) |
| 9:24-9:36 |
Reducing readmissions in elective colorectal surgery
J.H. Marks (USA)
|
| 9:36-9:56 |
Special Lecture: Radical Treatment of Carcinomatosis: Why and How?
M Deraco (Italy) |
| 9:56-10:20 |
Coffee Break |
| 10:20-10:32 |
Role of endoscopic stents as bridge to surgery
C Balagué (Spain) |
| 10:32-10:44 |
Does Sentinel Node technique have any role in GI malignancy?
J Meijerink (The Netherlands) |
| 10:44-10:56 |
Surgical audit by pathologist
M Berho (USA) |
| 10:56-11:08 |
Epigenetic biomarkers for colon cancer metastatic homing
M Perucho (Spain) |
| 11:08-11:20 |
Results of rectal cancer - COLOR II trial
J Bonjer (The Netherlands) |
| 11:20-11:32 |
Viking project (total mesorectal resection - TME)
E Espín (Spain) |
| 11:32-11:44 |
Challenges in implementing fast track surgery
N Francis (UK) |
| 11:44-11:56 |
Impact of pharmacological treatment in the postoperative ileus
JH Marks (USA)
|
| 11:56-12:08 |
From lab to clinical studies in oncology
C Nadal (Spain)
|
| 12:08-12:20 |
Tumor Response Assessment After Neoadjuvant CRT: What’s New?
RO Pérez (Brazil) |
| 12:20-12:50 |
Special Lecture: Proposal of multicentric study for rectal cancer
Background and Justification: Angelita Habr-Gama (Brazil)
Implementation: JH Marks (USA) |
| 12:50-13:50 |
Lunch |
| 13:50-15:30 |
Inflammatory Bowel Disease -ROOM J-
Chair: W Bemelman (The Netherlands)/J Panés (Spain) |
| 13:50-14:02 |
Advances in imaging in IBD
J Rimola (Spain) |
| 14:02-14:14 |
Ilean Crohn’s disease: surgery or medical treatment?
W Bemelman (The Netherlands) |
| 14:14-14:26 |
Cell therapies: is it an alternative to surgery?
J Panés (Spain) |
| 14:26-14:38 |
Single Incision Surgery for Ulcerative Colitis
T. Young-Fadok (USA)) |
| 14:38-14:50 |
Pouch Design and Long-term Functional Outcome: Does It Make a Difference?
T. Oresland (Norway) |
| 14:50-15:02 |
Optimizing Medical Therapy for Perianal Crohn’s Disease
E. Ricart (Spain) |
| 15:02-15:30 |
Special Lecture: Surgical Decision Making in the face of Indeterminate Colitis and Dysplasia
M. Berho (USA) |
| 15:30-16:26 |
Pelvic Floor -ROOM J-
Chair: R. Almenara (Spain)/S. Wexner (USA) |
15:30-15:50
|
Special Lecture: New Surgical Alternatives in the Treatment of Fecal Incontinence
S. Wexner (USA) |
15:50-16:02
|
Surgical treatment of rectocele
E Espín (Spain) |
16:02-16:14
|
Treatment of hemorrhoids: State of the Art in 2010
L Viso (Spain) |
16:14-16:26
|
Surgical management of rectourethral and recurrent recotovaginal fistulae
SD Wexner (USA) |
| 16:26-17:05 |
Coffee Break |
| 8:00-12:23 |
Obesity and Metabolic surgery -ROOM F-
Chair:P Schauer (USA)/ N Scopinario (Italy) |
| 8:00-8:48 |
Results of bariatric surgery (BMI>40):
- 8 :00-8 :12 Lap-band JM Chevallier (France)
- 8:12-8:24 Sleeve gastrectomy M Gagner (USA)
- 8:24-8:36 Gastric Bypass and Duodenal DiversionR. Cohen (Brazil)
- 8:36-8:48 Malabsortive techniques A. Baltasar (Spain)
|
| 8:48-9:03 |
Special Lecture: Why are lap-bands on the increase in the USA whereas in Europe are decreasing?
N Zundel (USA) |
| 9:03-9:51 |
Alternative strategies to treatment failure in obesity:
- 9:03-9:15 Banding J Pujol (Spain)
- 9:15-9:27 Sleeve gastrectomy M Gagner (USA)
- 9:27-9:39 Bypass R Weiner (Germany)
- 9:39-9:51 BPD N Scopinaro (Italy)
|
| 9:51-10:20 |
Coffee Break |
| 10:20-10:32 |
Role of GI Hormones in the surgical treatment of morbid obesity
J. Vidal (Spain)
|
| 10:32-10:44 |
Limits to results in the Swedish Obesity Study
H. Lönroth (Sweden) |
| 10:44-10:56 |
Type II Diabetes (T2DM): Indication for Surgery?
J. Vidal (Spain) |
| 10:56-11:08 |
Results of Ileal Transposition in T2DM
A. De Paula (Brazil) |
| 11:08-11:20 |
Results of Restrictive Techniques in T2DM
C. Boza (Chile)
|
| 11:20-11:35 |
Special Lecture: Preliminary Results of Surgery in T2DM
N. Scopinaro (Italy)
|
| 11:35-11:47 |
Gastric Plication
P. Schauer (USA)
|
| 11:47-11:59 |
Results of endosleeve in morbid obese patients
S Horgan (USA) |
| 11:59-12:11 |
Endoluminal Options
C Thompson (USA) |
| 12:11-12:23 |
New guidelines in surgical treatment of diabetes
F Rubino (USA) |
| 12:23-12:43 |
Special Lecture -ROOM F-
State of the Art of ERGE and Barrett Esophagus
T Demeester (USA) |
| 12:43-13:50 |
Lunch |
| 13:50-16:46 |
Upper GI -ROOM F-
Chair: T Demeester (USA)/KH Fuchs (Germany) |
| 13:50-14:02 |
What type of fundoplication after treatment of achalasia?
M Patti (USA) |
| 14:02-14:14 |
State of the art of endoscopic therapy for reflux and obesity
A Lobontiu (France) |
| 14:14-14:26 |
Type of repair in paraesophageal hernia
M Patti (USA) |
| 14:26-14:38 |
Current Management of Failed Antireflux Surgery
A Torres (Spain) |
| 14:38-14:50 |
Radiotherapy and/or chemotherapy: what's new in esophageal and gastric cancers
R Miralbell (Switzerland) |
| 14:50-15:02 |
Radiofrequency ablation in Barrett's esophagus
J Bergman (The Netherlands) |
| 15:02-15:14 |
Mucosal stripping in Barrett's esophagus
B Jobe (USA) |
| 15:14-15:26 |
Perioperative care in esophagectomy
G Martínez (Spain) |
| 15:26-15:38 |
Indications for Two-stage Esophagectomy
K.H. Fuchs (Germany)
|
| 15:38-15:50 |
Laparo and thoracoscopic surgery for esophageal squamous carcinoma with 3-field lymph node dissection.
H Inoue (Japan) |
| 15:50-16.02 |
Esophageal Cancer: radomized trial open vs lap
MA Cuesta (The Netherlands) |
| 16:02-16:14 |
Treatment of complications in esophageal surgery
M van Berge Henegouwen (The Netherlands) |
| 16:14-16:26 |
Is there indication of peritonectomy and hyperthermia in other type of tumors? (eg gastric tumors)
M Deraco (Italy) |
| 16:26-16:46 |
Special Lecture: Esophagus and MIS: Is it really an advantage?
L Swanstrom (USA) |
| 16:46-17:05 |
Coffee break |
| 17:05-18:58 |
Surgeons and New Technology: Dedicated to the Memory of Professor Gerhard F. Buess -ROOM J-
Chair: A. Szold (Israel)/M. Talamini (USA)
The Legacy of Professor Gerhard F. Buess
A. Szold/A. Lacy
|
| 17:10-17:22 |
New Surgery: New Platforms (Robotics vs Mechanical)
M Talamini (USA) |
| 17:22-17:34 |
Image Guided Liver Surgery: Is It Really Useful?
D Mutter (France) |
| 17:34-17:46 |
What Should The Relationship Between Industry and Medicine Be?
JM Piqué (Spain) |
| 17:46-17:58 |
What's New in Robotics?
M Anvari (Canada) |
| 17:58-18:10 |
A Novel Telesurgical System With Haptic Sensation
E. Ruíz (Italy)
|
| 18:10-18:22 |
Do we need new "toys" in laparoscopic surgery?
A Szold (Israel) |
| 18:22-18:34 |
Audit of intelligent OR
R Marvik (Norway) |
| 18:34-18:46 |
Reseach and patronage
V Arroyo (Spain) |
| 18:46-18:58 |
What Do We Need From a “New OR”?
J. Mangiardi (Switzerland) |
| 19:00-19:30 |
Special Lecture Systems biology: the next frontier in medical research -ROOM J-
A Agustí (Spain) |
